Aunitx
1 known investors
Auni Therapeutics develops immunotherapy treatments for food allergies, leveraging intralymphatic immunotherapy (ILIT) protocols and proprietary clinical innovations. The company serves patients with allergic disease and aims to bring next-generation allergen immunotherapies to market.
Founders & leadership
BL
Brad LangCo-Founder & Chief Executive Officer
AP
Amber PattersonCo-Founder & Chief Medical Officer
BP
Ben PattersonCo-Founder & Chief Operating Officer
Investors · 1
Frequently asked questions
- What does Aunitx do?
- Auni Therapeutics develops immunotherapy treatments for food allergies, leveraging intralymphatic immunotherapy (ILIT) protocols and proprietary clinical innovations. The company serves patients with allergic disease and aims to bring next-generation allergen immunotherapies to market.
- Who founded Aunitx?
- Aunitx was founded by Brad Lang, Amber Patterson, Ben Patterson.
- Who are Aunitx's investors?
- Aunitx's investors include JumpStart Equity.